Literature DB >> 15369795

Human papilloma virus type 16 infection and the early onset of cervical cancer.

Akihiro Karube1, Masahiro Sasaki, Hidenori Tanaka, Osamu Nakagome, Rajvir Dahiya, Seiichiro Fujimoto, Toshinobu Tanaka.   

Abstract

Human papilloma viruses (HPV), particularly type 16, have been associated with cervical cancer. It has been noted that the average onset of cervical cancer is occurring in younger women coupled with a higher prevalence of cervical HPV infection. However, the correlation between HPV 16 infection and the early onset of cervical cancer is still unclear. We hypothesize that HPV infection is an indicator of early onset of cervical cancer. To test this hypothesis, cervical smears from 197 women were evaluated by the polymerase chain reaction for HPV 16. These data revealed that the HPV 16-positive women were significantly younger than the HPV 16-negative women. Moreover, the average age of HPV 16-positive women with CIN 3 or invasive cancer was significantly younger compared with the other groups. These data clearly suggest that HPV 16 infection is a significant risk factor for the progression for cervical cancer in a young population of women. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15369795     DOI: 10.1016/j.bbrc.2004.08.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Dynamic response of HPV16/anti-HPV16 pairs with unbinding events studied by atomic force microscopy.

Authors:  Shiming Lin; Chung-Hung Hong; Bor-Ching Sheu; Long-Xin Wu; Wan-Chen Huang; Wei-Chih Huang; Cheng-Yan Guo
Journal:  Biochem Biophys Rep       Date:  2016-04-16

2.  Reduction in HPV 16/18 prevalence among young women following HPV vaccine introduction in a highly vaccinated district, Japan, 2008-2017.

Authors:  Akihiro Karube; Fumiko Saito; Enami Nakamura; Akihiro Shitara; Natsuki Ono; Megumi Konno; Daisuke Tamura; Daisuke Nagao
Journal:  J Rural Med       Date:  2019-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.